These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1696382

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG, Chen D, Ihse I, Rehfeld JF, Håkanson R.
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides.
    Schmidt WE, Choudhury AR, Siegel EG, Löser C, Conlon JM, Fölsch UR, Creutzfeldt W.
    Regul Pept; 1989 Jan; 24(1):67-79. PubMed ID: 2544930
    [Abstract] [Full Text] [Related]

  • 6. Effects of peptide YY on CCK/CCK antagonist interactions in cerulein-induced pancreatic injury.
    Tito JM, Rudnicki M, Robinson DC, Guiney WB, Adrian TE, Gold MS.
    Ann N Y Acad Sci; 1995 May 10; 757():410-2. PubMed ID: 7541974
    [No Abstract] [Full Text] [Related]

  • 7. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats.
    Papp M, Varga G, Folly G.
    Acta Physiol Hung; 1991 May 10; 78(1):61-7. PubMed ID: 1722380
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. On the importance of cholecystokinin in neonatal pancreatic growth and secretory development in guinea pigs.
    Herrington MK, Joekel CS, Vanderhoof JA, Adrian TE.
    Pancreas; 1995 Jul 10; 11(1):38-47. PubMed ID: 7545293
    [Abstract] [Full Text] [Related]

  • 13. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of hydrocortisone-treated rats.
    De Dios I, Manso MA.
    Pancreas; 1994 Mar 10; 9(2):212-8. PubMed ID: 7514791
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK, Permert J, Kazakoff KR, Pour PM, Zuker KA, Bilchik AJ, Adrian TE.
    Carcinogenesis; 1993 May 10; 14(5):1021-6. PubMed ID: 7684953
    [Abstract] [Full Text] [Related]

  • 16. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
    Varga G, Papp M, Scarpignato C.
    Fundam Clin Pharmacol; 1989 May 10; 3(3):295-306. PubMed ID: 2475419
    [Abstract] [Full Text] [Related]

  • 17. The role of CCK and its analogues in the organogenesis of the fetal rat pancreas.
    Feurle GE, Hamscher G, Firat AE.
    Pancreas; 1995 Apr 10; 10(3):281-6. PubMed ID: 7624305
    [Abstract] [Full Text] [Related]

  • 18. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
    Koop I, Lindenthal M, Schade M, Trautmann M, Adler G, Arnold R.
    Pancreas; 1991 Sep 10; 6(5):564-70. PubMed ID: 1946314
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.